Israël - hébreu - Ministry of Health

cure medical & technical supply - aminoacetic acid; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; l-serine; olive oil; soybean oil; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - soybean oil 60 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- threonine 4.4 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- valine 6.2 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; fish oil 30 g / 1000 ml; l-histidine 3.0 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l-serine 6.5 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; taurine 1.0 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; olive oil 50 g / 1000 ml - combinations

Israël - hébreu - Ministry of Health

cure medical & technical supply - aminoacetic acid; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; l-serine; olive oil; soybean oil; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; soybean oil 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- threonine 4.4 g / 1000 ml; taurine 1.0 g / 1000 ml; l-serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l-histidine 3.0 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; fish oil 30 g / 1000 ml - combinations

Israël - hébreu - Ministry of Health

neopharm (israel) 1996 ltd - calcium chloride dihydrate; fish oil; glucose monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium sulfate heptahydrate; olive oil; potassium chloride; sodium acetate trihydrate; sodium glycerophosphate hydrated; soya bean oil, refined; taurine; triglycerides, medium-chain; zinc sulfate heptahydrate - תחליב לאינפוזיה - soya bean oil, refined 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; zinc sulfate heptahydrate 0.0178 g / 1000 ml; sodium acetate trihydrate 4.1 g / 1000 ml; potassium chloride 3.48 g / 1000 ml; magnesium sulfate heptahydrate 1.92 g / 1000 ml; sodium glycerophosphate hydrated 3.48 g / 1000 ml; calcium chloride dihydrate 0.574 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- tryptophan 2 g / 1000 ml; taurine 1 g / 1000 ml; l- threonine 4.4 g / 1000 ml; l- serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l- leucine 7.4 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l-histidine 3.0 g / 1000 ml; glycine 11.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; fish oil 30 g / 1000 ml; olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml

Israël - hébreu - Ministry of Health

neopharm (israel) 1996 ltd - fish oil; glucose monohydrate; glycine; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; olive oil; soya bean oil, refined; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - fish oil 30 g / 1000 ml; olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; soya bean oil, refined 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- tryptophan 2 g / 1000 ml; l- threonine 4.4 g / 1000 ml; taurine 1 g / 1000 ml; l- serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l- isoleucine 5 g / 1000 ml; l-histidine 3 g / 1000 ml; glycine 11 g / 1000 ml; l-arginine 12 g / 1000 ml; l- alanine 14 g / 1000 ml

Israël - hébreu - Ministry of Health

soreq nuclear research cent./ isorad - tetrakis copper - tetrafluoroborate - אבקה מיובשת בהקפאה להזרקה - tetrakis copper - tetrafluoroborate 1 mg/vial - combinations - combinations - myocardial imaging. prognostication. pharmacologic stress. breast imaging.

Israël - hébreu - Ministry of Health

j-c health care ltd - doxorubicin hydrochloride - liposome for infusion - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin - doxorubicin - first or second line therapy of aids related kaposis sarcoma in patients with low cd 4 counts and extensive mucocutaneous or visceral disease the treatment of patients with metastatic carcinoma of the ovary who are refractory to both paclitaxel and platinium-based chemotherapy regimens and who may also be refractory to topotecan. refractory is defined as a patient having progressive disease while on treatment or within 6 months of completing treatmnt. as monotherapy for patients with metastatic breast cancer where there is an increased cardiac risk. in combination with bortezomib for the treatment of progressive multiplemyeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.

Israël - hébreu - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.

Israël - hébreu - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

Israël - hébreu - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

Israël - hébreu - Ministry of Health

novartis israel ltd - fulvestrant - תמיסה להזרקה - fulvestrant 50 mg/ml - fulvestrant